Skip to main content
. 2022 Mar 25;9(15):2103222. doi: 10.1002/advs.202103222

Figure 1.

Figure 1

Clinical trials involving exosomes, based on an analysis of clinical trials listed in clinicaltrial.gov (May 25th, 2021; search bar: “Other terms”; keyword: “Exosome”; exclusion: trials without FDA‐defined phases). More than 40% of the trials are cancer‐related (phase I–III); other trials (color coded) are investigating exosomes as diagnostic and therapeutic agents for mild cognitive impairment, Alzheimer's disease, heart failure, stroke, periodontitis, and other conditions.